Evaluation of an enzyme immunoassay for detection of immunoglobulin M antibodies to West Nile virus and the importance of background subtraction in detecting nonspecific reactivity

Clinical and Vaccine Immunology

Volumn 14, Issue 6, 2007, Pages 665-668

  Rawlins, Mindy L ^a   Swenson, Erica M ^b   Hill, Harry R ^a,b   Litwin, Christine M ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS ANTIGEN;

ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ARTICLE; BIOASSAY; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; HUMAN; INNATE IMMUNITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; WEST NILE FLAVIVIRUS;

ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE REACTIONS; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOGLOBULIN M; SENSITIVITY AND SPECIFICITY; WEST NILE VIRUS;

EID: 34547119521     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00480-06     Document Type: Article

References (21)

1. Campbell, G. L., A. A. Marfin, R. S. Lanciotti, and D. J. Gubler. 2002. West Nile virus. Lancet Infect. Dis. 2:519-529.
2. Centers for Disease Control and Prevention. 2003. Epidemic/epizootic West Nile virus in the United States: guidelines for surveillance, prevention, and control, 3rd ed. Centers for Disease Control and Prevention, Atlanta, GA.
3. Guharoy, R., S. A. Gilroy, J. A. Noviasky, and J. Ference. 2004. West Nile virus infection. Am. J. Health Syst. Pharm. 61:1235-1241.
4. Hogrefe, W. R., R. Moore, M. Lape-Nixon, M. Wagner, and H. E. Prince. 2004. Performance of immunoglobulin G (IgG) and IgM enzyme-linked immunosorbent assays using a West Nile virus recombinant antigen (preM/E) for detection of West Nile virus- and other flavivirus-speciflc antibodies. J. Clin. Microbiol. 42:4641-4648.
5. Huebner, J. 2004. Antibody-antigen interactions and measurements of immunologic reactions, p. 207-232. In G. Pier, J. Lyczak, and L. Wetzler (ed.), Immunology, infection, and immunity. ASM Press, Washington, DC.
6. Kim, M., and M. Wadke. 1990. Comparative evaluation of two test methods (enzyme immunoassay and latex fixation) for the detection of heterophil antibodies in infectious mononucleosis. J. Clin. Microbiol. 28:2511-2513.
7. Koraka, P., H. Zeller, M. Niedrig, A. D. Osterhaus, and J. Groen. 2002. Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect. 4:1209-1215.
8. Kricka, L. J. 1999. Human anti-animal antibody interferences in immunological assays. Clin. Chem. 45:942-956.
9. Levinson, S. S., and J. J. Miller. 2002. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin. Chim. Acta 325:1-15.
10. Malan, A. K., T. B. Martins, H. R. Hill, and C. M. Litwin. 2004. Evaluations of commercial West Nile virus immunoglobulin G (IgG) and IgM enzyme immunoassays show the value of continuous validation. J. Clin. Microbiol. 42:727-733.
11. Malan, A. K., P. J. Stipanovich, T. B. Martins, H. R. Hill, and C. M. Litwin. 2003. Detection of IgG and IgM to West Nile virus. Development of an immunofluorescence assay. Am. J. Clin. Pathol. 119:508-515.
12. Malkinson, M., C. Banet, Y. Weisman, S. Pokamunski, R. King, M. T. Drouet, and V. Deubel. 2002. Introduction of West Nile virus in the Middle East by migrating white storks. Emerg. Infect. Dis. 8:392-397.
13. Martins, T. B., T. D. Jaskowski, C. L. Mouritsen, and H. R. Hill. 1995. An evaluation of the effectiveness of three immunoglobulin G (IgG) removal procedures for routine IgM serological testing. Clin. Diagn. Lab. Immunol. 2:98-103.
14. Prince, H. E., and W. R. Hogrefe. 2003. Performance characteristics of an in-house assay system used to detect West Nile virus (WNV)-speciflc immunoglobulin M during the 2001 WNV season in the United States. Clin. Diagn. Lab. Immunol. 10:177-179.
15. Rappole, J. H., S. R. Derrickson, and Z. Hubalek. 2000. Migratory birds and spread of West Nile virus in the Western Hemisphere. Emerg. Infect. Dis. 6:319-328.
16. Roehrig, J. T., D. Nash, B. Maldin, A. Labowitz, D. A. Martin, R. S. Lanciotti, and G. L. Campbell. 2003. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg. Infect. Dis. 9:376-379.
17. Salonen, E. M., A. Vaheri, J. Suni, and O. Wager. 1980. Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay. J. Infect. Dis. 142:250-255.
18. Sambol, A. R., S. H. Hinrichs, W. R. Hogrefe, and B. K. Schweitzer. 2007. Performance of a commercial immunoglobulin M antibody capture assay using analyte-specific reagents to screen for interfering factors during a West Nile virus epidemic season in Nebraska. Clin. Vaccine Immunol. 14:87-89.
19. Smithburn, K. C., T. P. Hughes, A. W. Burke, and J. H. Paul. 1940. A neurotropic virus isolated from the blood of a native of Uganda. Am. J. Trop. Med. Hyg. 20:471-492.
20. Tilley, P. A., R. Walle, A. Chow, G. C. Jayaraman, K. Fonseca, M. A. Drebot, J. Preiksaitis, and J. Fox. 2005. Clinical utility of commercial enzyme immunoassays during the inaugural season of West Nile virus activity, Alberta, Canada. J. Clin. Microbiol. 43:4691-4695.
21. Turell, M. J., M. R. Sardelis, M. L. O'Guinn, and D. J. Dohm. 2002. Potential vectors of West Nile virus in North America. Curr. Top. Microbiol. Immunol. 267:241-252.